reports
Meitu Inc: 1 director
A director at Meitu Inc sold 66,050,180 shares at 2.915HKD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Kesko Oyj: 1 director
A director at Kesko Oyj bought 10,000 shares at 15.756EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
SSAB AB: 2 directors
Two Directors at SSAB AB bought 15,813 shares at between 60.100SEK and 61.060SEK. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
WiseTech Global Limited: 2 directors
Two Directors at WiseTech Global Limited sold 226,758 shares at 89.790AUD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
THG : 1 director
A director at THG bought 30,000 shares at 63p and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close ...
- Hiroyuki Terada
- Joel Scheiman
- Julie Boote
- Lindsay Whipp
- Nia Dokova
- Pelham Smithers
- William Nestuk
The PSA Weekly Research Round up for the week to 26 April 2024
Weekly Comment Summary After two weeks of seasonal-related buying at the start of April, foreign investors turned net sellers in the third week. Has foreign investor enthusiasm for Japanese shares come to an end? And is the yen to blame? Pelham Smithers investigates. PSA Company Visits, Tours and Interviews • Visited: CUC (9158 JT) • Conference Call with: Insource (6200 JT) • Presentations at: CUC (9158 JT), Shin-Etsu Chemical (4063 JT), TDK (6762 JT), Asahi Kasei (3407 JT), Nitto Denko (6988...
- ABGSC IT Research
- Alice Beer
- Nikola Kalanoski
Premier, Inc. Declares Quarterly Cash Dividend
CHARLOTTE, N.C.--(BUSINESS WIRE)-- Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on June 15, 2024, to stockholders of record as of the close of business on June 1, 2024. About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,350 U.S. hospitals and health systems and approximately 300,000 other providers and...
Manhattan Associates Wins Overall Innovation of the Year Award by Reta...
ATLANTA--(BUSINESS WIRE)-- (NASDAQ: MANH) today announced it has been named the winner of the Overall Innovation of the Year award by . Amongst thousands of nominations, Manhattan’s Fulfillment Experience Insights dashboard was recognized as the retail innovation best suited to help retailers succeed in today’s fast-transforming ecosystem. Included in , is a new and unique analytical tool. The first and only solution of its kind, this dashboard gives retailers a realtime and continuous assessment of how their omnichannel fulfillment performance stacks up against a large pool of peers and c...
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset...
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding for Pivotal Phase 3 trial in FAP An estimated 100,000 in U.S. and Europe are afflicted with FAP, precancerous polyps that typically lead to surgical removal of the colon and/or rectum In FAP, ...
Crédit Agricole Normandie Seine : communiqué financier trimestriel au ...
Crédit Agricole Normandie Seine : communiqué financier trimestriel au 31 mars 2024 RESULTATS AU 31 MARS 2024 Bois-Guillaume, le 26 avril 2024 Un premier trimestre de l’année 2024 impacté par un contexte économique en berne Impactée par le contexte économique européen de faible croissance, l’activité du 1er trimestre 2024 a été marquée par une faible dynamique d’investissement des entreprises et des ménages du territoire. Ce trimestre a été pour la Caisse Régionale Normandie-Seine un temps fort de rencontre de nos clients, illustrant l’intensité relationnelle que nous souhaito...
Correction Sono Group N.V. Announces Ticker Symbol Update and New Lead...
Correction Sono Group N.V. Announces Ticker Symbol Update and New Leadership Team as It Prepares for Market Advancement MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the trading symbol for the Company's ordinary shares and introduced the new leadership team. The original press release incorrectly stated that the Company's ordinary shares would be quoted on the over-the-counter market under the U.S. ticker ...
IperionX Titanium HAMR Furnace Installation Complete
CHARLOTTE, N.C.--(BUSINESS WIRE)-- IperionX Limited (NASDAQ: IPX, ASX: IPX) is pleased to announce a significant milestone in the development of commercial-scale titanium metal manufacturing capabilities at the Titanium Manufacturing Campus in Virginia. This press release features multimedia. View the full release here: Figure 1: HAMR Titanium Furnace at the IperionX Titanium Production Facility (Photo: Business Wire) The Hydrogen Assisted Metallothermic Reduction (HAMR TM) titanium furnace has been delivered and successfully installed, with first energization and commissioning on track to co...
CEMATRIX Announces $7.6 Million in New Contracts and a Reduction in Sc...
CEMATRIX Announces $7.6 Million in New Contracts and a Reduction in Scope of a Previously Awarded Tunnel Project CALGARY, Alberta, April 26, 2024 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company") a North American leading manufacturer and supplier of technologically advanced cellular concrete products today announced that it has executed $7.6 million in new contracts. A portion of the $7.6 million in new contracts is derived from two projects, with price tags greater than $1 million Canadian, and were previously included in Contracts in Proc...
Allogene Therapeutics Awarded Grant from the California Institute for ...
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma $15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)ALLO-316 Illustrates Proof-of-Concept in RCC and the Potential of Dagger® Technology to Optimize CAR T Cell Expansion and Persistence SOUTH SAN FRANCISCO, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology comp...
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Complianc...
Bannix Acquisition Corp. Receives Nasdaq Notification of Non-Compliance With Listing Rules WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did not...
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previousl...
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda — If approved in the European Union, fruquintinib will be the first novel targeted therapy for metastatic colorectal cancer regardless of biomarker status in over a decade — — Positive opinion based on results from FRESCO-2 Phase III clinical trial — HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“”) (Nasdaq/AIM:HCM; HKEX:13) today announces that its partner (TSE:4502/NYSE:TAK) received noti...
LiveOne (NASDAQ: LVO) Expands Pay-Per-View Lineup with “KnuckleMania ...
LiveOne (NASDAQ: LVO) Expands Pay-Per-View Lineup with “KnuckleMania IV” Partnering with Bare Knuckle (BKFC) for “Perry vs. Alves" PPV Event on Saturday, April 27, 2024 PPV Tickets Available for $29.99 at LiveOne.com LiveOne Continues to Dominate Live Streaming with Impressive Milestones: 252,268 PPV Tickets Sold200+ Million Viewers Reached5 Billion Engagements with Fans Across 220 Countries Highlighted PPV Events: Wiz Khalifa, MonsterX, Pitbull Social GlovesFloyd Mayweather vs. Logan PaulFloyd Mayweather vs. DejiIce Wars III: Outlaw EnforcersShowstar UK vs USA: Deji vs. WassabiGlobal...
VCI Global Announces Earnings Call and Business Update on April 30th, ...
VCI Global Announces Earnings Call and Business Update on April 30th, 2024 KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor conference call at 8:00 a.m. Eastern Time on Tuesday, April 30th, 2024. “We are very excited and look forward to sharing with our investors the growth that our company has seen over this last year,” stated Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. Please call the conference telepho...
ALPHAMIN DECLARES FINAL FY2023 DIVIDEND
ALPHAMIN DECLARES FINAL FY2023 DIVIDEND GRAND BAIE, MAURITIUS, April 26, 2024 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX)( “Alphamin” or the “Company”) announced today that its Board of Directors has declared a Final FY2023 cash dividend of CAD$0.03 per share on the common shares (approximately US$27.9 million in the aggregate) (the “Dividend”). The Dividend will be payable on 24 May, 2024 to shareholders of record as of the close of business on 17 May, 2024. _________________________________________________________________________________________ FOR MORE INFO...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.